LGC COVID-19 antibody assay processes up to 40,000 tests per day in UK

News - First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection

23 September 2020
LGC announces new senior appointments

News - LGC has announced three new senior appointments

17 September 2020
Measurement for Recovery (M4R) launched to boost UK innovation

News - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

27 August 2020
LGC and Aptahem combine on first large-scale production campaign of Apta-1

News - First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

13 August 2020
Kent consortium gets green light to develop £60million investment bid: proposal to accelerate medicines development via data and digital technology

News - A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

11 August 2020
LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

28 July 2020
LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

15 July 2020
LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

09 July 2020
NML response to the Research and Development Roadmap

News - The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it

03 July 2020
LGC and Q2 Solutions announce global bioanalytical strategic partnership

News - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach

26 June 2020